Author

Sylvie Jacod

Institution: Translational Research in Oncology

Observed institutions: Translational Research in Oncology, Université Pierre-et-Marie-Curie

OpenAlex ID: A5018932859

Regulatory Dysfunction of the Interleukin-7 Receptor in CD4 and CD8 Lymphocytes From HIV-Infected Patients-Effects of Antiretroviral Therapy

2006 · Jean-Hervé Colle, Jean-Louis Moreau, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 73

Identification of a Clinical-Grade Maturation Factor for Dendritic Cells

2002 · Claire Boccaccio, Sylvie Jacod, et al. · Journal of Immunotherapy · 43

A multicenter open-label phase II study of the efficacy and safety of ganitumab (AMG 479), a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R) as second-line therapy in patients with recurrent platinum-sensitive ovarian cancer.

2013 · Isabelle Ray-Coquard, Paul Haluska, et al. · Journal of Clinical Oncology · 18

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with carboplatin/paclitaxel as front-line therapy for optimally debulked primary ovarian cancer: The TRIO14 trial.

2014 · Gottfried E. Konecny, Paul Haluska, et al. · Journal of Clinical Oncology · 7

Regulatory Dysfunction of the Interleukin-7 Receptor in CD4 and CD8 Lymphocytes From HIV-Infected Patients-Effects of Antiretroviral Therapy

2006 · Jean-Herv?? Colle, Jean-Louis Moreau, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1

Macrophages for Immunotherapy

2004 · Delphine Loirat, Sylvie Jacod, et al. · Antibodies

Works count: 6

Citation count: 142

H-index: 4

I10-index: 3